nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—Cytochrome P450 3A Inducers—Phenytoin—epilepsy syndrome	0.156	0.295	CiPCiCtD
Efavirenz—Cytochrome P450 2B6 Inducers—Carbamazepine—epilepsy syndrome	0.146	0.277	CiPCiCtD
Efavirenz—Cytochrome P450 2B6 Inducers—Phenytoin—epilepsy syndrome	0.13	0.247	CiPCiCtD
Efavirenz—Cytochrome P450 2C19 Inhibitors—Topiramate—epilepsy syndrome	0.0948	0.18	CiPCiCtD
Efavirenz—CYP2C19—epilepsy syndrome	0.0741	0.574	CbGaD
Efavirenz—CYP2D6—epilepsy syndrome	0.055	0.426	CbGaD
Efavirenz—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0106	0.0439	CbGbCtD
Efavirenz—CYP2B6—Clobazam—epilepsy syndrome	0.0092	0.0381	CbGbCtD
Efavirenz—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00772	0.0319	CbGbCtD
Efavirenz—CYP2B6—Carbamazepine—epilepsy syndrome	0.00763	0.0315	CbGbCtD
Efavirenz—CYP2C19—Trimethadione—epilepsy syndrome	0.00717	0.0297	CbGbCtD
Efavirenz—CYP2C19—Felbamate—epilepsy syndrome	0.00717	0.0297	CbGbCtD
Efavirenz—CYP2B6—Primidone—epilepsy syndrome	0.00712	0.0294	CbGbCtD
Efavirenz—CYP2B6—Phenytoin—epilepsy syndrome	0.00684	0.0283	CbGbCtD
Efavirenz—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00675	0.0279	CbGbCtD
Efavirenz—CYP2B6—Propofol—epilepsy syndrome	0.00638	0.0264	CbGbCtD
Efavirenz—CYP2B6—Phenobarbital—epilepsy syndrome	0.0061	0.0252	CbGbCtD
Efavirenz—CYP2B6—Midazolam—epilepsy syndrome	0.00601	0.0249	CbGbCtD
Efavirenz—CYP2C9—Trimethadione—epilepsy syndrome	0.00596	0.0247	CbGbCtD
Efavirenz—CYP2C19—Clobazam—epilepsy syndrome	0.00585	0.0242	CbGbCtD
Efavirenz—CYP2B6—Diazepam—epilepsy syndrome	0.00578	0.0239	CbGbCtD
Efavirenz—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00561	0.0232	CbGbCtD
Efavirenz—CYP2C19—Carbamazepine—epilepsy syndrome	0.00485	0.02	CbGbCtD
Efavirenz—CYP2B6—Valproic Acid—epilepsy syndrome	0.00456	0.0188	CbGbCtD
Efavirenz—CYP2C19—Primidone—epilepsy syndrome	0.00452	0.0187	CbGbCtD
Efavirenz—CYP1A2—Carbamazepine—epilepsy syndrome	0.00447	0.0185	CbGbCtD
Efavirenz—CYP2C19—Phenytoin—epilepsy syndrome	0.00435	0.018	CbGbCtD
Efavirenz—CYP1A2—Primidone—epilepsy syndrome	0.00417	0.0173	CbGbCtD
Efavirenz—CYP2C19—Propofol—epilepsy syndrome	0.00405	0.0168	CbGbCtD
Efavirenz—CYP2C9—Carbamazepine—epilepsy syndrome	0.00403	0.0167	CbGbCtD
Efavirenz—CYP2C19—Phenobarbital—epilepsy syndrome	0.00387	0.016	CbGbCtD
Efavirenz—CYP2C9—Primidone—epilepsy syndrome	0.00376	0.0156	CbGbCtD
Efavirenz—CYP1A2—Propofol—epilepsy syndrome	0.00374	0.0155	CbGbCtD
Efavirenz—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00373	0.0154	CbGbCtD
Efavirenz—CYP2C19—Diazepam—epilepsy syndrome	0.00367	0.0152	CbGbCtD
Efavirenz—CYP2C9—Phenytoin—epilepsy syndrome	0.00361	0.0149	CbGbCtD
Efavirenz—CYP2C19—Zonisamide—epilepsy syndrome	0.00358	0.0148	CbGbCtD
Efavirenz—CYP1A2—Phenobarbital—epilepsy syndrome	0.00357	0.0148	CbGbCtD
Efavirenz—CYP3A4—Trimethadione—epilepsy syndrome	0.00347	0.0143	CbGbCtD
Efavirenz—CYP3A4—Felbamate—epilepsy syndrome	0.00347	0.0143	CbGbCtD
Efavirenz—CYP1A2—Diazepam—epilepsy syndrome	0.00339	0.014	CbGbCtD
Efavirenz—CYP2C9—Propofol—epilepsy syndrome	0.00337	0.0139	CbGbCtD
Efavirenz—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00326	0.0135	CbGbCtD
Efavirenz—CYP2C9—Phenobarbital—epilepsy syndrome	0.00322	0.0133	CbGbCtD
Efavirenz—CYP2D6—Propofol—epilepsy syndrome	0.00308	0.0127	CbGbCtD
Efavirenz—CYP2C9—Diazepam—epilepsy syndrome	0.00305	0.0126	CbGbCtD
Efavirenz—CYP3A4—Clonazepam—epilepsy syndrome	0.00295	0.0122	CbGbCtD
Efavirenz—CYP2C19—Valproic Acid—epilepsy syndrome	0.0029	0.012	CbGbCtD
Efavirenz—CYP3A4—Clobazam—epilepsy syndrome	0.00283	0.0117	CbGbCtD
Efavirenz—CYP1A2—Valproic Acid—epilepsy syndrome	0.00267	0.011	CbGbCtD
Efavirenz—CYP2C19—Topiramate—epilepsy syndrome	0.00261	0.0108	CbGbCtD
Efavirenz—CYP2C9—Valproic Acid—epilepsy syndrome	0.00241	0.00995	CbGbCtD
Efavirenz—CYP3A4—Rufinamide—epilepsy syndrome	0.0024	0.00994	CbGbCtD
Efavirenz—CYP3A4—Carbamazepine—epilepsy syndrome	0.00234	0.00969	CbGbCtD
Efavirenz—CYP3A4—Primidone—epilepsy syndrome	0.00219	0.00904	CbGbCtD
Efavirenz—CYP3A4—Phenytoin—epilepsy syndrome	0.0021	0.00869	CbGbCtD
Efavirenz—CYP3A4—Propofol—epilepsy syndrome	0.00196	0.0081	CbGbCtD
Efavirenz—CYP3A4—Acetazolamide—epilepsy syndrome	0.00187	0.00774	CbGbCtD
Efavirenz—CYP3A4—Phenobarbital—epilepsy syndrome	0.00187	0.00774	CbGbCtD
Efavirenz—CYP3A4—Midazolam—epilepsy syndrome	0.00185	0.00764	CbGbCtD
Efavirenz—CYP3A4—Diazepam—epilepsy syndrome	0.00178	0.00734	CbGbCtD
Efavirenz—CYP3A4—Zonisamide—epilepsy syndrome	0.00173	0.00716	CbGbCtD
Efavirenz—CYP3A4—Valproic Acid—epilepsy syndrome	0.0014	0.00579	CbGbCtD
Efavirenz—CYP3A4—Topiramate—epilepsy syndrome	0.00126	0.00522	CbGbCtD
Efavirenz—Vomiting—Diazepam—epilepsy syndrome	1.48e-05	0.000156	CcSEcCtD
Efavirenz—Anorexia—Valproic Acid—epilepsy syndrome	1.47e-05	0.000156	CcSEcCtD
Efavirenz—Tremor—Gabapentin—epilepsy syndrome	1.47e-05	0.000155	CcSEcCtD
Efavirenz—Rash—Diazepam—epilepsy syndrome	1.46e-05	0.000155	CcSEcCtD
Efavirenz—Dermatitis—Diazepam—epilepsy syndrome	1.46e-05	0.000155	CcSEcCtD
Efavirenz—Visual impairment—Topiramate—epilepsy syndrome	1.46e-05	0.000154	CcSEcCtD
Efavirenz—Arthralgia—Pregabalin—epilepsy syndrome	1.46e-05	0.000154	CcSEcCtD
Efavirenz—Myalgia—Pregabalin—epilepsy syndrome	1.46e-05	0.000154	CcSEcCtD
Efavirenz—Chest pain—Pregabalin—epilepsy syndrome	1.46e-05	0.000154	CcSEcCtD
Efavirenz—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.46e-05	0.000154	CcSEcCtD
Efavirenz—Dizziness—Zonisamide—epilepsy syndrome	1.46e-05	0.000154	CcSEcCtD
Efavirenz—Headache—Diazepam—epilepsy syndrome	1.45e-05	0.000154	CcSEcCtD
Efavirenz—Anxiety—Pregabalin—epilepsy syndrome	1.45e-05	0.000153	CcSEcCtD
Efavirenz—Diarrhoea—Clonazepam—epilepsy syndrome	1.45e-05	0.000153	CcSEcCtD
Efavirenz—Anaemia—Gabapentin—epilepsy syndrome	1.45e-05	0.000153	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.45e-05	0.000153	CcSEcCtD
Efavirenz—Asthenia—Carbamazepine—epilepsy syndrome	1.44e-05	0.000153	CcSEcCtD
Efavirenz—Agitation—Gabapentin—epilepsy syndrome	1.44e-05	0.000152	CcSEcCtD
Efavirenz—Diarrhoea—Phenytoin—epilepsy syndrome	1.44e-05	0.000152	CcSEcCtD
Efavirenz—Discomfort—Pregabalin—epilepsy syndrome	1.44e-05	0.000152	CcSEcCtD
Efavirenz—Nausea—Fosphenytoin—epilepsy syndrome	1.44e-05	0.000152	CcSEcCtD
Efavirenz—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.43e-05	0.000152	CcSEcCtD
Efavirenz—Erythema multiforme—Topiramate—epilepsy syndrome	1.43e-05	0.000152	CcSEcCtD
Efavirenz—Angioedema—Gabapentin—epilepsy syndrome	1.43e-05	0.000152	CcSEcCtD
Efavirenz—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.43e-05	0.000151	CcSEcCtD
Efavirenz—Vomiting—Felbamate—epilepsy syndrome	1.43e-05	0.000151	CcSEcCtD
Efavirenz—Dry mouth—Pregabalin—epilepsy syndrome	1.42e-05	0.000151	CcSEcCtD
Efavirenz—Pruritus—Carbamazepine—epilepsy syndrome	1.42e-05	0.00015	CcSEcCtD
Efavirenz—Rash—Felbamate—epilepsy syndrome	1.42e-05	0.00015	CcSEcCtD
Efavirenz—Eye disorder—Topiramate—epilepsy syndrome	1.42e-05	0.00015	CcSEcCtD
Efavirenz—Dermatitis—Felbamate—epilepsy syndrome	1.42e-05	0.00015	CcSEcCtD
Efavirenz—Malaise—Gabapentin—epilepsy syndrome	1.41e-05	0.00015	CcSEcCtD
Efavirenz—Tinnitus—Topiramate—epilepsy syndrome	1.41e-05	0.000149	CcSEcCtD
Efavirenz—Vertigo—Gabapentin—epilepsy syndrome	1.41e-05	0.000149	CcSEcCtD
Efavirenz—Headache—Felbamate—epilepsy syndrome	1.41e-05	0.000149	CcSEcCtD
Efavirenz—Confusional state—Pregabalin—epilepsy syndrome	1.41e-05	0.000149	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.41e-05	0.000149	CcSEcCtD
Efavirenz—Cardiac disorder—Topiramate—epilepsy syndrome	1.41e-05	0.000149	CcSEcCtD
Efavirenz—Flushing—Topiramate—epilepsy syndrome	1.41e-05	0.000149	CcSEcCtD
Efavirenz—Syncope—Gabapentin—epilepsy syndrome	1.41e-05	0.000149	CcSEcCtD
Efavirenz—Dizziness—Clonazepam—epilepsy syndrome	1.4e-05	0.000148	CcSEcCtD
Efavirenz—Nausea—Vigabatrin—epilepsy syndrome	1.4e-05	0.000148	CcSEcCtD
Efavirenz—Vomiting—Zonisamide—epilepsy syndrome	1.4e-05	0.000148	CcSEcCtD
Efavirenz—Insomnia—Valproic Acid—epilepsy syndrome	1.4e-05	0.000148	CcSEcCtD
Efavirenz—Asthenia—Lamotrigine—epilepsy syndrome	1.39e-05	0.000147	CcSEcCtD
Efavirenz—Dizziness—Phenytoin—epilepsy syndrome	1.39e-05	0.000147	CcSEcCtD
Efavirenz—Rash—Zonisamide—epilepsy syndrome	1.39e-05	0.000147	CcSEcCtD
Efavirenz—Paraesthesia—Valproic Acid—epilepsy syndrome	1.39e-05	0.000147	CcSEcCtD
Efavirenz—Palpitations—Gabapentin—epilepsy syndrome	1.39e-05	0.000147	CcSEcCtD
Efavirenz—Dermatitis—Zonisamide—epilepsy syndrome	1.39e-05	0.000147	CcSEcCtD
Efavirenz—Dizziness—Oxcarbazepine—epilepsy syndrome	1.39e-05	0.000147	CcSEcCtD
Efavirenz—Nausea—Diazepam—epilepsy syndrome	1.38e-05	0.000146	CcSEcCtD
Efavirenz—Loss of consciousness—Gabapentin—epilepsy syndrome	1.38e-05	0.000146	CcSEcCtD
Efavirenz—Headache—Zonisamide—epilepsy syndrome	1.38e-05	0.000146	CcSEcCtD
Efavirenz—Dyspnoea—Valproic Acid—epilepsy syndrome	1.38e-05	0.000146	CcSEcCtD
Efavirenz—Diarrhoea—Carbamazepine—epilepsy syndrome	1.38e-05	0.000145	CcSEcCtD
Efavirenz—Angiopathy—Topiramate—epilepsy syndrome	1.38e-05	0.000145	CcSEcCtD
Efavirenz—Pruritus—Lamotrigine—epilepsy syndrome	1.37e-05	0.000145	CcSEcCtD
Efavirenz—Shock—Pregabalin—epilepsy syndrome	1.37e-05	0.000145	CcSEcCtD
Efavirenz—Somnolence—Valproic Acid—epilepsy syndrome	1.37e-05	0.000145	CcSEcCtD
Efavirenz—Immune system disorder—Topiramate—epilepsy syndrome	1.37e-05	0.000145	CcSEcCtD
Efavirenz—Nervous system disorder—Pregabalin—epilepsy syndrome	1.37e-05	0.000145	CcSEcCtD
Efavirenz—Cough—Gabapentin—epilepsy syndrome	1.37e-05	0.000145	CcSEcCtD
Efavirenz—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.37e-05	0.000145	CcSEcCtD
Efavirenz—Mediastinal disorder—Topiramate—epilepsy syndrome	1.37e-05	0.000144	CcSEcCtD
Efavirenz—Tachycardia—Pregabalin—epilepsy syndrome	1.36e-05	0.000144	CcSEcCtD
Efavirenz—Dyspepsia—Valproic Acid—epilepsy syndrome	1.36e-05	0.000144	CcSEcCtD
Efavirenz—Convulsion—Gabapentin—epilepsy syndrome	1.36e-05	0.000144	CcSEcCtD
Efavirenz—Skin disorder—Pregabalin—epilepsy syndrome	1.36e-05	0.000143	CcSEcCtD
Efavirenz—Hypertension—Gabapentin—epilepsy syndrome	1.35e-05	0.000143	CcSEcCtD
Efavirenz—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.35e-05	0.000143	CcSEcCtD
Efavirenz—Vomiting—Clonazepam—epilepsy syndrome	1.35e-05	0.000143	CcSEcCtD
Efavirenz—Decreased appetite—Valproic Acid—epilepsy syndrome	1.34e-05	0.000142	CcSEcCtD
Efavirenz—Alopecia—Topiramate—epilepsy syndrome	1.34e-05	0.000142	CcSEcCtD
Efavirenz—Vomiting—Phenytoin—epilepsy syndrome	1.34e-05	0.000142	CcSEcCtD
Efavirenz—Rash—Clonazepam—epilepsy syndrome	1.34e-05	0.000141	CcSEcCtD
Efavirenz—Dermatitis—Clonazepam—epilepsy syndrome	1.34e-05	0.000141	CcSEcCtD
Efavirenz—Chest pain—Gabapentin—epilepsy syndrome	1.34e-05	0.000141	CcSEcCtD
Efavirenz—Arthralgia—Gabapentin—epilepsy syndrome	1.34e-05	0.000141	CcSEcCtD
Efavirenz—Myalgia—Gabapentin—epilepsy syndrome	1.34e-05	0.000141	CcSEcCtD
Efavirenz—Nausea—Felbamate—epilepsy syndrome	1.34e-05	0.000141	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.33e-05	0.000141	CcSEcCtD
Efavirenz—Vomiting—Oxcarbazepine—epilepsy syndrome	1.33e-05	0.000141	CcSEcCtD
Efavirenz—Fatigue—Valproic Acid—epilepsy syndrome	1.33e-05	0.000141	CcSEcCtD
Efavirenz—Anxiety—Gabapentin—epilepsy syndrome	1.33e-05	0.000141	CcSEcCtD
Efavirenz—Anorexia—Pregabalin—epilepsy syndrome	1.33e-05	0.000141	CcSEcCtD
Efavirenz—Dizziness—Carbamazepine—epilepsy syndrome	1.33e-05	0.000141	CcSEcCtD
Efavirenz—Diarrhoea—Lamotrigine—epilepsy syndrome	1.33e-05	0.000141	CcSEcCtD
Efavirenz—Headache—Clonazepam—epilepsy syndrome	1.33e-05	0.000141	CcSEcCtD
Efavirenz—Rash—Phenytoin—epilepsy syndrome	1.33e-05	0.00014	CcSEcCtD
Efavirenz—Dermatitis—Phenytoin—epilepsy syndrome	1.33e-05	0.00014	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.33e-05	0.00014	CcSEcCtD
Efavirenz—Rash—Oxcarbazepine—epilepsy syndrome	1.32e-05	0.00014	CcSEcCtD
Efavirenz—Constipation—Valproic Acid—epilepsy syndrome	1.32e-05	0.00014	CcSEcCtD
Efavirenz—Pain—Valproic Acid—epilepsy syndrome	1.32e-05	0.00014	CcSEcCtD
Efavirenz—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.32e-05	0.00014	CcSEcCtD
Efavirenz—Headache—Phenytoin—epilepsy syndrome	1.32e-05	0.00014	CcSEcCtD
Efavirenz—Malnutrition—Topiramate—epilepsy syndrome	1.32e-05	0.00014	CcSEcCtD
Efavirenz—Erythema—Topiramate—epilepsy syndrome	1.32e-05	0.00014	CcSEcCtD
Efavirenz—Discomfort—Gabapentin—epilepsy syndrome	1.32e-05	0.00014	CcSEcCtD
Efavirenz—Headache—Oxcarbazepine—epilepsy syndrome	1.31e-05	0.000139	CcSEcCtD
Efavirenz—Nausea—Zonisamide—epilepsy syndrome	1.31e-05	0.000138	CcSEcCtD
Efavirenz—Dry mouth—Gabapentin—epilepsy syndrome	1.31e-05	0.000138	CcSEcCtD
Efavirenz—Flatulence—Topiramate—epilepsy syndrome	1.3e-05	0.000138	CcSEcCtD
Efavirenz—Tension—Topiramate—epilepsy syndrome	1.29e-05	0.000137	CcSEcCtD
Efavirenz—Dysgeusia—Topiramate—epilepsy syndrome	1.29e-05	0.000137	CcSEcCtD
Efavirenz—Confusional state—Gabapentin—epilepsy syndrome	1.29e-05	0.000137	CcSEcCtD
Efavirenz—Dizziness—Lamotrigine—epilepsy syndrome	1.28e-05	0.000136	CcSEcCtD
Efavirenz—Nervousness—Topiramate—epilepsy syndrome	1.28e-05	0.000136	CcSEcCtD
Efavirenz—Vomiting—Carbamazepine—epilepsy syndrome	1.28e-05	0.000135	CcSEcCtD
Efavirenz—Back pain—Topiramate—epilepsy syndrome	1.28e-05	0.000135	CcSEcCtD
Efavirenz—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.27e-05	0.000135	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.27e-05	0.000135	CcSEcCtD
Efavirenz—Rash—Carbamazepine—epilepsy syndrome	1.27e-05	0.000134	CcSEcCtD
Efavirenz—Dermatitis—Carbamazepine—epilepsy syndrome	1.27e-05	0.000134	CcSEcCtD
Efavirenz—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.26e-05	0.000134	CcSEcCtD
Efavirenz—Insomnia—Pregabalin—epilepsy syndrome	1.26e-05	0.000134	CcSEcCtD
Efavirenz—Nausea—Clonazepam—epilepsy syndrome	1.26e-05	0.000133	CcSEcCtD
Efavirenz—Headache—Carbamazepine—epilepsy syndrome	1.26e-05	0.000133	CcSEcCtD
Efavirenz—Shock—Gabapentin—epilepsy syndrome	1.26e-05	0.000133	CcSEcCtD
Efavirenz—Nervous system disorder—Gabapentin—epilepsy syndrome	1.26e-05	0.000133	CcSEcCtD
Efavirenz—Paraesthesia—Pregabalin—epilepsy syndrome	1.25e-05	0.000133	CcSEcCtD
Efavirenz—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.25e-05	0.000133	CcSEcCtD
Efavirenz—Nausea—Phenytoin—epilepsy syndrome	1.25e-05	0.000132	CcSEcCtD
Efavirenz—Tachycardia—Gabapentin—epilepsy syndrome	1.25e-05	0.000132	CcSEcCtD
Efavirenz—Dyspnoea—Pregabalin—epilepsy syndrome	1.24e-05	0.000132	CcSEcCtD
Efavirenz—Nausea—Oxcarbazepine—epilepsy syndrome	1.24e-05	0.000132	CcSEcCtD
Efavirenz—Vision blurred—Topiramate—epilepsy syndrome	1.24e-05	0.000132	CcSEcCtD
Efavirenz—Skin disorder—Gabapentin—epilepsy syndrome	1.24e-05	0.000132	CcSEcCtD
Efavirenz—Somnolence—Pregabalin—epilepsy syndrome	1.24e-05	0.000131	CcSEcCtD
Efavirenz—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.24e-05	0.000131	CcSEcCtD
Efavirenz—Tremor—Topiramate—epilepsy syndrome	1.24e-05	0.000131	CcSEcCtD
Efavirenz—Vomiting—Lamotrigine—epilepsy syndrome	1.24e-05	0.000131	CcSEcCtD
Efavirenz—Urticaria—Valproic Acid—epilepsy syndrome	1.23e-05	0.00013	CcSEcCtD
Efavirenz—Rash—Lamotrigine—epilepsy syndrome	1.23e-05	0.00013	CcSEcCtD
Efavirenz—Ill-defined disorder—Topiramate—epilepsy syndrome	1.22e-05	0.000129	CcSEcCtD
Efavirenz—Dermatitis—Lamotrigine—epilepsy syndrome	1.22e-05	0.000129	CcSEcCtD
Efavirenz—Abdominal pain—Valproic Acid—epilepsy syndrome	1.22e-05	0.000129	CcSEcCtD
Efavirenz—Body temperature increased—Valproic Acid—epilepsy syndrome	1.22e-05	0.000129	CcSEcCtD
Efavirenz—Anorexia—Gabapentin—epilepsy syndrome	1.22e-05	0.000129	CcSEcCtD
Efavirenz—Anaemia—Topiramate—epilepsy syndrome	1.22e-05	0.000129	CcSEcCtD
Efavirenz—Headache—Lamotrigine—epilepsy syndrome	1.22e-05	0.000129	CcSEcCtD
Efavirenz—Decreased appetite—Pregabalin—epilepsy syndrome	1.21e-05	0.000128	CcSEcCtD
Efavirenz—Agitation—Topiramate—epilepsy syndrome	1.21e-05	0.000128	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.21e-05	0.000127	CcSEcCtD
Efavirenz—Fatigue—Pregabalin—epilepsy syndrome	1.2e-05	0.000127	CcSEcCtD
Efavirenz—Nausea—Carbamazepine—epilepsy syndrome	1.19e-05	0.000126	CcSEcCtD
Efavirenz—Pain—Pregabalin—epilepsy syndrome	1.19e-05	0.000126	CcSEcCtD
Efavirenz—Constipation—Pregabalin—epilepsy syndrome	1.19e-05	0.000126	CcSEcCtD
Efavirenz—Malaise—Topiramate—epilepsy syndrome	1.19e-05	0.000126	CcSEcCtD
Efavirenz—Vertigo—Topiramate—epilepsy syndrome	1.19e-05	0.000125	CcSEcCtD
Efavirenz—Syncope—Topiramate—epilepsy syndrome	1.18e-05	0.000125	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.17e-05	0.000123	CcSEcCtD
Efavirenz—Palpitations—Topiramate—epilepsy syndrome	1.17e-05	0.000123	CcSEcCtD
Efavirenz—Loss of consciousness—Topiramate—epilepsy syndrome	1.16e-05	0.000123	CcSEcCtD
Efavirenz—Insomnia—Gabapentin—epilepsy syndrome	1.16e-05	0.000122	CcSEcCtD
Efavirenz—Nausea—Lamotrigine—epilepsy syndrome	1.15e-05	0.000122	CcSEcCtD
Efavirenz—Cough—Topiramate—epilepsy syndrome	1.15e-05	0.000122	CcSEcCtD
Efavirenz—Feeling abnormal—Pregabalin—epilepsy syndrome	1.15e-05	0.000122	CcSEcCtD
Efavirenz—Paraesthesia—Gabapentin—epilepsy syndrome	1.15e-05	0.000122	CcSEcCtD
Efavirenz—Convulsion—Topiramate—epilepsy syndrome	1.14e-05	0.000121	CcSEcCtD
Efavirenz—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.14e-05	0.000121	CcSEcCtD
Efavirenz—Dyspnoea—Gabapentin—epilepsy syndrome	1.14e-05	0.000121	CcSEcCtD
Efavirenz—Hypertension—Topiramate—epilepsy syndrome	1.14e-05	0.00012	CcSEcCtD
Efavirenz—Somnolence—Gabapentin—epilepsy syndrome	1.14e-05	0.00012	CcSEcCtD
Efavirenz—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.14e-05	0.00012	CcSEcCtD
Efavirenz—Dyspepsia—Gabapentin—epilepsy syndrome	1.13e-05	0.000119	CcSEcCtD
Efavirenz—Chest pain—Topiramate—epilepsy syndrome	1.12e-05	0.000119	CcSEcCtD
Efavirenz—Arthralgia—Topiramate—epilepsy syndrome	1.12e-05	0.000119	CcSEcCtD
Efavirenz—Myalgia—Topiramate—epilepsy syndrome	1.12e-05	0.000119	CcSEcCtD
Efavirenz—Anxiety—Topiramate—epilepsy syndrome	1.12e-05	0.000118	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.12e-05	0.000118	CcSEcCtD
Efavirenz—Decreased appetite—Gabapentin—epilepsy syndrome	1.11e-05	0.000118	CcSEcCtD
Efavirenz—Discomfort—Topiramate—epilepsy syndrome	1.11e-05	0.000117	CcSEcCtD
Efavirenz—Urticaria—Pregabalin—epilepsy syndrome	1.11e-05	0.000117	CcSEcCtD
Efavirenz—Asthenia—Valproic Acid—epilepsy syndrome	1.11e-05	0.000117	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.11e-05	0.000117	CcSEcCtD
Efavirenz—Fatigue—Gabapentin—epilepsy syndrome	1.1e-05	0.000117	CcSEcCtD
Efavirenz—Body temperature increased—Pregabalin—epilepsy syndrome	1.1e-05	0.000117	CcSEcCtD
Efavirenz—Abdominal pain—Pregabalin—epilepsy syndrome	1.1e-05	0.000117	CcSEcCtD
Efavirenz—Dry mouth—Topiramate—epilepsy syndrome	1.1e-05	0.000116	CcSEcCtD
Efavirenz—Constipation—Gabapentin—epilepsy syndrome	1.09e-05	0.000116	CcSEcCtD
Efavirenz—Pain—Gabapentin—epilepsy syndrome	1.09e-05	0.000116	CcSEcCtD
Efavirenz—Pruritus—Valproic Acid—epilepsy syndrome	1.09e-05	0.000116	CcSEcCtD
Efavirenz—Confusional state—Topiramate—epilepsy syndrome	1.09e-05	0.000115	CcSEcCtD
Efavirenz—Shock—Topiramate—epilepsy syndrome	1.06e-05	0.000112	CcSEcCtD
Efavirenz—Diarrhoea—Valproic Acid—epilepsy syndrome	1.06e-05	0.000112	CcSEcCtD
Efavirenz—Nervous system disorder—Topiramate—epilepsy syndrome	1.06e-05	0.000112	CcSEcCtD
Efavirenz—Feeling abnormal—Gabapentin—epilepsy syndrome	1.05e-05	0.000112	CcSEcCtD
Efavirenz—Thrombocytopenia—Topiramate—epilepsy syndrome	1.05e-05	0.000112	CcSEcCtD
Efavirenz—Tachycardia—Topiramate—epilepsy syndrome	1.05e-05	0.000111	CcSEcCtD
Efavirenz—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.05e-05	0.000111	CcSEcCtD
Efavirenz—Skin disorder—Topiramate—epilepsy syndrome	1.05e-05	0.000111	CcSEcCtD
Efavirenz—Hyperhidrosis—Topiramate—epilepsy syndrome	1.04e-05	0.00011	CcSEcCtD
Efavirenz—Hypersensitivity—Pregabalin—epilepsy syndrome	1.03e-05	0.000109	CcSEcCtD
Efavirenz—Anorexia—Topiramate—epilepsy syndrome	1.03e-05	0.000109	CcSEcCtD
Efavirenz—Dizziness—Valproic Acid—epilepsy syndrome	1.02e-05	0.000108	CcSEcCtD
Efavirenz—Urticaria—Gabapentin—epilepsy syndrome	1.02e-05	0.000108	CcSEcCtD
Efavirenz—Abdominal pain—Gabapentin—epilepsy syndrome	1.01e-05	0.000107	CcSEcCtD
Efavirenz—Body temperature increased—Gabapentin—epilepsy syndrome	1.01e-05	0.000107	CcSEcCtD
Efavirenz—Asthenia—Pregabalin—epilepsy syndrome	1e-05	0.000106	CcSEcCtD
Efavirenz—Pruritus—Pregabalin—epilepsy syndrome	9.88e-06	0.000104	CcSEcCtD
Efavirenz—Vomiting—Valproic Acid—epilepsy syndrome	9.82e-06	0.000104	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.81e-06	0.000104	CcSEcCtD
Efavirenz—Insomnia—Topiramate—epilepsy syndrome	9.74e-06	0.000103	CcSEcCtD
Efavirenz—Rash—Valproic Acid—epilepsy syndrome	9.74e-06	0.000103	CcSEcCtD
Efavirenz—Dermatitis—Valproic Acid—epilepsy syndrome	9.73e-06	0.000103	CcSEcCtD
Efavirenz—Headache—Valproic Acid—epilepsy syndrome	9.67e-06	0.000102	CcSEcCtD
Efavirenz—Paraesthesia—Topiramate—epilepsy syndrome	9.67e-06	0.000102	CcSEcCtD
Efavirenz—Dyspnoea—Topiramate—epilepsy syndrome	9.6e-06	0.000102	CcSEcCtD
Efavirenz—Somnolence—Topiramate—epilepsy syndrome	9.57e-06	0.000101	CcSEcCtD
Efavirenz—Diarrhoea—Pregabalin—epilepsy syndrome	9.55e-06	0.000101	CcSEcCtD
Efavirenz—Dyspepsia—Topiramate—epilepsy syndrome	9.48e-06	0.0001	CcSEcCtD
Efavirenz—Hypersensitivity—Gabapentin—epilepsy syndrome	9.43e-06	9.97e-05	CcSEcCtD
Efavirenz—Decreased appetite—Topiramate—epilepsy syndrome	9.36e-06	9.9e-05	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.3e-06	9.83e-05	CcSEcCtD
Efavirenz—Fatigue—Topiramate—epilepsy syndrome	9.28e-06	9.82e-05	CcSEcCtD
Efavirenz—Dizziness—Pregabalin—epilepsy syndrome	9.23e-06	9.76e-05	CcSEcCtD
Efavirenz—Pain—Topiramate—epilepsy syndrome	9.21e-06	9.74e-05	CcSEcCtD
Efavirenz—Constipation—Topiramate—epilepsy syndrome	9.21e-06	9.74e-05	CcSEcCtD
Efavirenz—Asthenia—Gabapentin—epilepsy syndrome	9.18e-06	9.71e-05	CcSEcCtD
Efavirenz—Nausea—Valproic Acid—epilepsy syndrome	9.17e-06	9.7e-05	CcSEcCtD
Efavirenz—Pruritus—Gabapentin—epilepsy syndrome	9.06e-06	9.58e-05	CcSEcCtD
Efavirenz—Vomiting—Pregabalin—epilepsy syndrome	8.88e-06	9.39e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Topiramate—epilepsy syndrome	8.87e-06	9.39e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.81e-06	9.31e-05	CcSEcCtD
Efavirenz—Rash—Pregabalin—epilepsy syndrome	8.8e-06	9.31e-05	CcSEcCtD
Efavirenz—Dermatitis—Pregabalin—epilepsy syndrome	8.79e-06	9.3e-05	CcSEcCtD
Efavirenz—Diarrhoea—Gabapentin—epilepsy syndrome	8.76e-06	9.26e-05	CcSEcCtD
Efavirenz—Headache—Pregabalin—epilepsy syndrome	8.75e-06	9.25e-05	CcSEcCtD
Efavirenz—Urticaria—Topiramate—epilepsy syndrome	8.56e-06	9.05e-05	CcSEcCtD
Efavirenz—Body temperature increased—Topiramate—epilepsy syndrome	8.51e-06	9e-05	CcSEcCtD
Efavirenz—Abdominal pain—Topiramate—epilepsy syndrome	8.51e-06	9e-05	CcSEcCtD
Efavirenz—Dizziness—Gabapentin—epilepsy syndrome	8.46e-06	8.95e-05	CcSEcCtD
Efavirenz—Nausea—Pregabalin—epilepsy syndrome	8.29e-06	8.77e-05	CcSEcCtD
Efavirenz—Vomiting—Gabapentin—epilepsy syndrome	8.14e-06	8.61e-05	CcSEcCtD
Efavirenz—Rash—Gabapentin—epilepsy syndrome	8.07e-06	8.54e-05	CcSEcCtD
Efavirenz—Dermatitis—Gabapentin—epilepsy syndrome	8.06e-06	8.53e-05	CcSEcCtD
Efavirenz—Headache—Gabapentin—epilepsy syndrome	8.02e-06	8.48e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Topiramate—epilepsy syndrome	7.93e-06	8.39e-05	CcSEcCtD
Efavirenz—Asthenia—Topiramate—epilepsy syndrome	7.73e-06	8.17e-05	CcSEcCtD
Efavirenz—Pruritus—Topiramate—epilepsy syndrome	7.62e-06	8.06e-05	CcSEcCtD
Efavirenz—Nausea—Gabapentin—epilepsy syndrome	7.6e-06	8.04e-05	CcSEcCtD
Efavirenz—Diarrhoea—Topiramate—epilepsy syndrome	7.37e-06	7.79e-05	CcSEcCtD
Efavirenz—Dizziness—Topiramate—epilepsy syndrome	7.12e-06	7.53e-05	CcSEcCtD
Efavirenz—Vomiting—Topiramate—epilepsy syndrome	6.85e-06	7.24e-05	CcSEcCtD
Efavirenz—Rash—Topiramate—epilepsy syndrome	6.79e-06	7.18e-05	CcSEcCtD
Efavirenz—Dermatitis—Topiramate—epilepsy syndrome	6.78e-06	7.17e-05	CcSEcCtD
Efavirenz—Headache—Topiramate—epilepsy syndrome	6.75e-06	7.14e-05	CcSEcCtD
Efavirenz—Nausea—Topiramate—epilepsy syndrome	6.4e-06	6.77e-05	CcSEcCtD
Efavirenz—CYP1A2—Metabolism—COX3—epilepsy syndrome	3.62e-06	0.000459	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	3.56e-06	0.000452	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	3.53e-06	0.000448	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AQP1—epilepsy syndrome	3.53e-06	0.000447	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	3.52e-06	0.000446	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PDXK—epilepsy syndrome	3.49e-06	0.000443	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	3.49e-06	0.000443	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	3.49e-06	0.000443	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—FAR1—epilepsy syndrome	3.49e-06	0.000443	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CERS1—epilepsy syndrome	3.49e-06	0.000443	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADK—epilepsy syndrome	3.49e-06	0.000443	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GBE1—epilepsy syndrome	3.44e-06	0.000436	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	3.44e-06	0.000436	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PFKL—epilepsy syndrome	3.43e-06	0.000435	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	3.43e-06	0.000435	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	3.43e-06	0.000435	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	3.43e-06	0.000435	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	3.43e-06	0.000435	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	3.42e-06	0.000434	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	3.41e-06	0.000432	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GBE1—epilepsy syndrome	3.41e-06	0.000432	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.35e-06	0.000425	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NT5E—epilepsy syndrome	3.34e-06	0.000423	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALAD—epilepsy syndrome	3.34e-06	0.000423	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.34e-06	0.000423	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.33e-06	0.000422	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	3.24e-06	0.00041	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	3.21e-06	0.000407	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	3.19e-06	0.000405	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PNPO—epilepsy syndrome	3.19e-06	0.000405	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	3.19e-06	0.000405	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GAMT—epilepsy syndrome	3.19e-06	0.000405	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—KCNJ11—epilepsy syndrome	3.19e-06	0.000404	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CHRM3—epilepsy syndrome	3.19e-06	0.000404	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	3.18e-06	0.000403	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	3.18e-06	0.000403	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	3.15e-06	0.000399	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ATIC—epilepsy syndrome	3.14e-06	0.000398	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—UPB1—epilepsy syndrome	3.14e-06	0.000398	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NEU1—epilepsy syndrome	3.14e-06	0.000398	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	3.12e-06	0.000396	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	3.11e-06	0.000395	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NT5E—epilepsy syndrome	3.07e-06	0.000389	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALAD—epilepsy syndrome	3.07e-06	0.000389	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADSL—epilepsy syndrome	3.05e-06	0.000387	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NT5E—epilepsy syndrome	3.04e-06	0.000385	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALAD—epilepsy syndrome	3.04e-06	0.000385	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	3.02e-06	0.000383	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GLUL—epilepsy syndrome	2.99e-06	0.000379	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.97e-06	0.000376	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.97e-06	0.000376	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.96e-06	0.000375	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	2.94e-06	0.000372	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	2.93e-06	0.000371	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	2.93e-06	0.000371	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GBE1—epilepsy syndrome	2.92e-06	0.00037	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	2.92e-06	0.00037	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	2.9e-06	0.000368	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	2.9e-06	0.000368	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	2.86e-06	0.000363	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.85e-06	0.000361	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	2.84e-06	0.00036	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADSL—epilepsy syndrome	2.81e-06	0.000356	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—COX3—epilepsy syndrome	2.79e-06	0.000354	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADSL—epilepsy syndrome	2.78e-06	0.000353	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GLUL—epilepsy syndrome	2.75e-06	0.000349	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	2.75e-06	0.000348	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	2.74e-06	0.000347	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GLUL—epilepsy syndrome	2.73e-06	0.000346	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	2.7e-06	0.000342	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	2.68e-06	0.000339	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	2.67e-06	0.000338	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AQP1—epilepsy syndrome	2.67e-06	0.000338	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.65e-06	0.000335	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.65e-06	0.000335	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.65e-06	0.000335	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.65e-06	0.000335	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.65e-06	0.000335	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	2.6e-06	0.00033	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NT5E—epilepsy syndrome	2.6e-06	0.000329	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALAD—epilepsy syndrome	2.6e-06	0.000329	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.56e-06	0.000325	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	2.54e-06	0.000321	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	2.53e-06	0.00032	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	2.52e-06	0.000319	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	2.51e-06	0.000317	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	2.48e-06	0.000314	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	2.48e-06	0.000314	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.45e-06	0.000311	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.43e-06	0.000308	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.43e-06	0.000308	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.42e-06	0.000307	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.42e-06	0.000307	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.42e-06	0.000307	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.41e-06	0.000306	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.41e-06	0.000306	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.38e-06	0.000301	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.34e-06	0.000296	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.33e-06	0.000295	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.33e-06	0.000295	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2.29e-06	0.00029	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	2.27e-06	0.000288	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.25e-06	0.000285	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.25e-06	0.000285	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.25e-06	0.000285	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.22e-06	0.000281	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.22e-06	0.000281	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.2e-06	0.000279	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.2e-06	0.000279	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.2e-06	0.000279	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	2.17e-06	0.000274	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—BCHE—epilepsy syndrome	2.16e-06	0.000273	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.14e-06	0.000271	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.12e-06	0.000268	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AQP1—epilepsy syndrome	2.08e-06	0.000263	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.06e-06	0.000261	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.06e-06	0.000261	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.05e-06	0.00026	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.03e-06	0.000258	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TH—epilepsy syndrome	2.03e-06	0.000257	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.01e-06	0.000254	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.01e-06	0.000254	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.01e-06	0.000254	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2e-06	0.000253	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.97e-06	0.000249	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.91e-06	0.000243	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.91e-06	0.000243	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.9e-06	0.000241	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.89e-06	0.00024	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.88e-06	0.000238	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.88e-06	0.000238	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.87e-06	0.000237	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.83e-06	0.000233	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.81e-06	0.000229	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.8e-06	0.000228	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.79e-06	0.000227	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.77e-06	0.000224	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.76e-06	0.000223	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.75e-06	0.000222	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.75e-06	0.000222	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.75e-06	0.000221	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.74e-06	0.00022	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.72e-06	0.000218	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.72e-06	0.000218	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.72e-06	0.000218	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.71e-06	0.000217	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.69e-06	0.000214	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.67e-06	0.000212	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.65e-06	0.000209	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.64e-06	0.000207	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.63e-06	0.000206	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.62e-06	0.000206	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.6e-06	0.000203	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.57e-06	0.000199	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.57e-06	0.000199	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.55e-06	0.000197	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.54e-06	0.000195	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.53e-06	0.000194	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TH—epilepsy syndrome	1.53e-06	0.000194	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.51e-06	0.000191	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.51e-06	0.000191	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.5e-06	0.000191	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.5e-06	0.00019	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.49e-06	0.000189	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.49e-06	0.000189	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.49e-06	0.000188	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.48e-06	0.000188	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.47e-06	0.000187	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.45e-06	0.000184	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.45e-06	0.000184	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.43e-06	0.000181	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.42e-06	0.00018	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.41e-06	0.000179	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TH—epilepsy syndrome	1.41e-06	0.000179	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.4e-06	0.000178	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TH—epilepsy syndrome	1.4e-06	0.000177	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.38e-06	0.000174	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.34e-06	0.00017	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.34e-06	0.00017	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.32e-06	0.000168	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.3e-06	0.000164	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.28e-06	0.000162	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.27e-06	0.000162	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.27e-06	0.000161	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.26e-06	0.00016	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.23e-06	0.000156	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.21e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.2e-06	0.000152	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TH—epilepsy syndrome	1.19e-06	0.000151	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.18e-06	0.00015	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.18e-06	0.000149	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.18e-06	0.000149	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.17e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.16e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.15e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.15e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.15e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.14e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.13e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.12e-06	0.000142	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.11e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.05e-06	0.000133	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.04e-06	0.000132	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.03e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.02e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AGT—epilepsy syndrome	1e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	9.96e-07	0.000126	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	9.84e-07	0.000125	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAT—epilepsy syndrome	9.83e-07	0.000125	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOE—epilepsy syndrome	9.8e-07	0.000124	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BCHE—epilepsy syndrome	9.8e-07	0.000124	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	9.56e-07	0.000121	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.35e-07	0.000118	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.24e-07	0.000117	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TH—epilepsy syndrome	9.21e-07	0.000117	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AGT—epilepsy syndrome	9.2e-07	0.000117	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AGT—epilepsy syndrome	9.12e-07	0.000116	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOE—epilepsy syndrome	9.02e-07	0.000114	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOE—epilepsy syndrome	8.94e-07	0.000113	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPX1—epilepsy syndrome	8.89e-07	0.000113	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	8.89e-07	0.000113	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—POMC—epilepsy syndrome	8.42e-07	0.000107	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AGT—epilepsy syndrome	7.79e-07	9.88e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—POMC—epilepsy syndrome	7.74e-07	9.81e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	7.69e-07	9.74e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—POMC—epilepsy syndrome	7.68e-07	9.73e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—epilepsy syndrome	7.68e-07	9.73e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOE—epilepsy syndrome	7.64e-07	9.68e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAT—epilepsy syndrome	7.59e-07	9.61e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.38e-07	9.35e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—epilepsy syndrome	7.06e-07	8.95e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—epilepsy syndrome	7e-07	8.87e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.86e-07	8.69e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	6.72e-07	8.51e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—POMC—epilepsy syndrome	6.56e-07	8.31e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	6.18e-07	7.83e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	6.12e-07	7.76e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.02e-07	7.62e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—epilepsy syndrome	5.98e-07	7.58e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.89e-07	7.47e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	5.23e-07	6.63e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.06e-07	6.42e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.62e-07	5.85e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—epilepsy syndrome	4.47e-07	5.66e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.04e-07	5.12e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.38e-07	4.28e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.1e-07	3.93e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.08e-07	3.9e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.63e-07	3.33e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.03e-07	2.57e-05	CbGpPWpGaD
